A doctor from Menorca warns about the effects of AstraZeneca: 19 teachers attended between 23 and 62 years

An emergency doctor at the Mateu Orfila Hospital, the main one in Menorca, assures that in the last month they have seen 19 people pass through her unit who had expressed discomfort after receiving the

The doctor, named Nadiya Popel, tells the local newspaper that her intention is not “to create controversy, or criticize, or confront anyone, but I think it is necessary to give people information so that they reflect and decide.”

Two admissions and 19 patients from the teaching group

Popel, a Spaniard of Ukrainian origin and a hospital worker for more than 15 years, points out that over the last month of those 19 people inoculated with the Anglo-Swedish serum who have gone through the emergency room, two ended up admitted. They were all teaching staff of different profiles between 23 and 62 years old; 14 women and 5 men.

Of the two people who have required admission, one has manifested suspicions of meningoencephalitis. The other was admitted due to severe headache and leg pain that required a neurological study.

Popel says that he has informed the hospital authorities, but that in his opinion the administration of the vaccine should be stopped. “Maybe we should look at healthier ways to get by.”

“I understand that we all want to find a way out of this difficult situation, but we have to ask ourselves at what price and if there are no better options than this,” he argues.

The controversy with AstraZeneca does not stop

The words of this doctor add to the long trail of comings and goings of the AstraZeneca vaccine, paralyzed in several countries until , although recognizing the relationship between thrombi and the dose.

See also  Here's why the microchip shortage is shrinking

However, knowing that the benefits far outweigh the risks, as have also been stated by experts such as

The Government of Spain has also had its comings and goings, changing the criteria this Thursday and announcing that it will supply this vaccine for people, without specifying that it will cause younger people -many of them teachers- who have received the first dose.

Loading Facebook Comments ...
Loading Disqus Comments ...